Hi, I'm

YVANKA GILLIAM

MBA, PharmD

SPECIALTIES

Oncology and Diagnostics with a focus on Thoracic and GI/GU Malignancies and Rare Diseases.

INTERESTS

Biotechnology, Pharmaceutical, Diagnostic, Device, Genetic testing, Consulting Companies, and CROs

TARGET REGIONS

Emerging Markets in the Asia Pacific, Middle East, and Africa regions.

Clinical & Business Executive:

Oncology Pharmaceutical / Biotechnology & Diagnostics

Driven and outcome-focused executive who operates at the intersection of clinical oncology, medical affairs, and business development, providing a therapeutic perspective to influence commercial growth. Experience spans pharmaceutical, biotechnology, diagnostics and devices with vast real world evidence experience within Asia Pacific (APAC), Middle East, Africa, and the United States. 

Strategies &
Expertise

Product Strategy

Track record of identifying market gaps and seizing untapped opportunities to commercialize cutting-edge products and services. Wealth of experience in launch success by bringing new products to market and in label expansions to emerging markets. A trusted advisor, skilled in pre-launch disease state education, key opinion leadership and marketing through pipeline-building and post-launch success, ensuring an increase in product uptake and utilization.

  • Launched nine (9) oncology compounds including a companion diagnostic in the United States and in Emerging markets.
  • Expanded Kantar Health real world evidence offerings into new verticals and markets across multiple regions. Pioneered customized, integrated real world, qualitative, and quantitative product suites, monetized hospital databases, and created innovative revenue streams for publishing abstracts of collaboration projects with pharmaceutical and biotechnology clients.
  • Commercialized and launched IQVIA’s syndicated registry network and observational studies in 14 countries, generating $2.8M in revenue in under a year. Delivered a 60% increase in IQVIA’s client base in the APAC region by expanding the client base to include multinational companies and indigenous clients.

Business Strategy & Operations

Strategic with short and long-term vision in executing business objectives that gain traction, drive momentum, and fuel swift and explosive company growth. Transformed business models; built lean operations; championed innovation. MBA in International Business. Expertise in international business strategy and business development underscored by a multicultural perspective honed by extensive travel to over 52 countries.

  • Operationalized Diaceutics Asia Pacific entityfor the launch of the world’s first diagnostic commercialization platform for precision medicine.
  • Driver of extensive and sustainable business growth with pharmaceutical, biotechnology, and indigenous clients; triggered triple-digit percentage growth in annual revenue and significantly increased customer accounts.
  • Turned around IQVIA’s APAC real world evidence market performance and produced $2.8M in revenue in under a year.

Leverage Clinical Expertise to Build Business

Expert relationship-builder, consultant, and advisor to key opinion leader (KOLs). Peer to peer collaboration with oncologists in the development of products that drive global market penetration, and extensive and sustainable business growth.

  • Established network of global KOLs, leveraging in-depth clinical knowledge.
  • Positioned Kantar Health in the global market as a real-world evidence strategic partner to pharmaceutical and biotechnology companies across APAC.
Previous
Next

Career
Highlights

Dec 2020 – Present
Diaceutics PTE
Vice President for Operations, Asia Pacific, Middle East, and Africa

Data and analytics implementation company providing pharmaceutical companies with the world’s first diagnostic commercialization platform for precision medicine – DXRX, The Diagnostic Network®.

Nov 2019 – Nov 2020
Kantar Health
Senior Client Partner, Real World Evidence (RWE) Oncology and Rare Diseases

Kantar Health is the world’s leading data analytics, insights and consulting company.

Sep 2017 – Nov 2019
IQVIA Asia-Pacific
Principal, Strategy-Life Sciences │ Head of APAC Registry and Observational Studies, Real World Insights Division

The largest healthcare data science company and leader in human data science technology.

Sep 2015 – Sep 2017
AstraZeneca Pharmaceutical Corporation
Senior Medical Science Liaison, Thoracic Cancer-Immuno-Oncology

A global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines.

Mar 2010 – Sep 2015
Boehringer Ingelheim Pharmaceuticals, Inc.
Associate Director, Field Based Medicine Field Based Medical Affairs – Oncology

Afatinib Compound Lead, supported the Squamous Cell Carcinoma of the Head and Neck (SCCHN) program.

Mar 2005 – Feb 2010
Millennium Pharmaceutical Company
Senior Medical Science Liaison

Millennium brings a strong oncology commercial presence and holds responsibility for the promotion of VELCADE within the United States.

Sep 2004 – Mar 2005
Aventis Pharmaceutical Company
Manager, Professional Medical Education
Aventis is one of the world’s leading pharmaceutical corporations. Its core businesses are the discovery, development and marketing of innovative products in the fields of prescription drugs, vaccines and animal health.
2002 – 2004
Eli Lilly Pharmaceutical Company
Associate Marketing Manager

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.

2001
Eli Lilly Pharmaceutical Company
Executive Oncology Business Development Specialist

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.

2000
Eli Lilly Pharmaceutical Company
Senior Clinical Project Manager

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.

Education

Master of Business Administration, International Business

Rutgers Business School
Singapore

Doctor of Pharmacy

University of Michigan
Ann Arbor, MI, USA

Bachelor of Science, Biology focusing upon Biochemistry

Grambling University
Grambling, LA, USA

Affiliations

American Society of Clinical Oncology
American Society of Hematology
European Society for Medical Oncology
International Association for the Study of Lung Cancer
Society for Health Economics and Outcomes Research
Scroll to Top
Scroll to Top